+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis



Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis



Tumour Biology 35(2): 935-942



Epidemiological studies have evaluated the association between transforming growth factor-β1 (TGF-β1) -509C/T polymorphisms and breast cancer risk. However, the results remain conflicting rather than conclusive. The aim of this study was to comprehensively clarify the association between TGF-β1 -509C/T polymorphisms and breast cancer risk. All relevant studies were searched in the electronic databases. The potential sources of heterogeneity were detected with the chi-square-based Q test. The strength of associations between TGF-β1 -509C/T polymorphisms and breast cancer risk was measured by odds ratio (OR) and 95 % confidence intervals (CI). Publication bias was tested by Begg's test and Egger's test. A total of 10 studies including 10,913 cases and 14,187 controls were included in the meta-analysis. Overall, there was no evidence of significant association of TGF-β1 -509C/T polymorphisms with breast cancer risk (TT vs. CC [OR = 0.97, 95 % CI = 0.83-1.14]; CT vs. CC [OR = 1.05, 95 % CI = 0.90-1.22]; TT + CT vs. CC [OR = 0.99, 95 % CI = 0.91-1.08]; T allele vs. C allele [OR = 0.99, 95 % CI = 0.93-1.06]). Similar results were also found in the subgroup analyses by ethnicity and source of control. When stratified by estrogen receptor (ER) status, TT genotype and T allele were associated with a decreased ER-positive breast cancer risk (OR = 0.66, 95 % CI = 0.49-0.90 and OR = 0.85, 95 % CI = 0.75-0.96, respectively). The present meta-analysis results suggest that TGF-β1 -509C/T variants may not contribute to the risk of breast cancer overall. However, T allele may be a potential protective factor for developing ER-positive breast cancer. Well-designed studies with larger sample size were required to verify our findings further.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051681022

Download citation: RISBibTeXText

PMID: 23982878

DOI: 10.1007/s13277-013-1122-3


Related references

An updated meta-analysis on the association of TGF-β1 gene promoter -509C/T polymorphism with colorectal cancer risk. Cytokine 61(1): 181-187, 2013

Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies. Asian Pacific Journal of Cancer Prevention 15(22): 9643-9647, 2014

Effects of interleukin-10 polymorphisms (rs1800896, rs1800871, and rs1800872) on breast cancer risk: evidence from an updated meta-analysis. Genetic Testing and Molecular Biomarkers 18(6): 439-445, 2014

MTHFR gene A1298C polymorphisms are associated with breast cancer risk among Chinese population: evidence based on an updated cumulative meta-analysis. International Journal of Clinical and Experimental Medicine 8(11): 20146-20156, 2015

Association between two common polymorphisms and risk of hepatocellular carcinoma: evidence from an updated meta-analysis. Biomed Research International 2014: 468605, 2014

Association between the HOTAIR polymorphisms and cancer risk: an updated meta-analysis. Oncotarget 8(3): 4460-4470, 2017

Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis. Asian Pacific Journal of Cancer Prevention 15(6): 2889-2892, 2014

Association of CYP1A1 polymorphisms with prostate cancer risk: an updated meta-analysis. Molecular Biology Reports 39(12): 10273-10284, 2012

Association between VDR polymorphisms and breast cancer: an updated and comparative meta-analysis of crude and adjusted odd ratios. Asian Pacific Journal of Cancer Prevention 15(2): 847-853, 2014

Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis. Tumour Biology 35(6): 5149-5158, 2014

Association of mir-196a-2 rs11614913 and mir-149 rs2292832 Polymorphisms With Risk of Cancer: An Updated Meta-Analysis. Frontiers in Genetics 10: 186, 2019

Associations between TLR9 polymorphisms and cancer risk: evidence from an updated meta-analysis of 25,685 subjects. Asian Pacific Journal of Cancer Prevention 15(19): 8279-8285, 2014

Association between PSCA gene polymorphisms and the risk of cancer: an updated meta-analysis and trial sequential analysis. Oncotarget 8(31): 51766-51778, 2017

The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis. Tumour Biology 35(4): 3597-3603, 2014

Association between TLR4 (+896A/G and +1196C/T) polymorphisms and gastric cancer risk: an updated meta-analysis. Plos one 9(10): E109605, 2014